文献速递妇科

黑人女性子宫内膜癌诊断评估中对活检优先方法的可接受性促进因素与障碍

Facilitators and barriers to acceptability of a biopsy-first approach in the diagnostic evaluation for endometrial cancer among Black women.
PubMed 文献 · Am J Obstet Gynecol · 2025-03-12

本研究为社区参与的质性研究,通过3个焦点小组访谈25名有子宫内膜癌风险的顺性别黑人女性,探讨活检优先诊断方法的可接受性。参与者初期因既往不良体验和医疗种族主义认知而抵触,但最终总体接受活检作为排除子宫内膜癌的优先检测。促进因素包括建立信任、共享信息和教育,障碍包括负面既往体验和医疗种族主义事件。

要点

  • 黑人女性子宫内膜癌5年死亡率是白人患者的2倍以上,部分归因于晚期诊断比例更高。
  • 经阴道超声作为活检分诊工具在黑人女性中表现不佳,活检优先可能改善及时诊断。
  • 通过信任建立、共享决策和教育可提高活检优先方法的可接受性。

核心结论

  • 黑人顺性别女性最终总体接受活检作为排除子宫内膜癌的优先检测,但初期存在抵触。
  • 以患者为中心的沟通方法结合信任建立、共享决策和教育,在推荐活检时可能最为成功。

研究设计与样本

  • 社区参与的质性研究,在25名有子宫内膜癌风险的顺性别黑人女性中开展3个焦点小组,每组6至10人。
  • 采用方便抽样通过社交媒体和通讯网络招募,焦点小组指南基于计划行为理论制定。
  • 转录资料采用归纳与演绎结合的方法编码,并运用定向和主题内容分析。

主要发现

  • 参与者初期对有症状情况下活检优先方法表达可理解的忧虑和拒绝,受既往不良体验和医疗种族主义认知影响。
  • 到焦点小组结束时,活检作为排除子宫内膜癌的优先检测总体可接受。
  • 活检可接受性的障碍包括负面既往体验(如疼痛预期与实际体验不匹配)和已知的医疗种族主义事件。
  • 促进因素包括通过明确承认医疗种族主义、分享信息、个性化建议和照护中的种族一致性来培养医患信任。
  • 促进因素还包括关于子宫内膜癌种族差异、活检操作、放弃活检的身体风险、活检的情绪益处及可能疼痛范围范围的健康教育。

临床怎么用

  • 作者认为,推荐活检时采用结合信任建立、共享决策和教育的以患者为中心的沟通方法可能最为成功。
  • 这些发现可为文化胜任的临床指南制定和公共健康教育提供信息,以改善黑人女性子宫内膜癌的及时诊断和最终生存。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Black people in the United States with endometrial cancer have a 5-year mortality rate that is more than twice that of White patients. This disparity is driven, in part, by Black individuals' higher likelihood of advanced-stage diagnosis. Transvaginal ultrasound-as a triage tool for referral to tissue sampling-underperforms among Black women. In this context, tissue sampling as an early step for symptomatic Black patients may improve timely diagnosis of endometrial cancer. Patient acceptability of biopsy as a priority test is necessary to ensure success of this clinical approach. Yet, little is known about the perspective of Black women on biopsy in the diagnostic workup for endometrial cancer. OBJECTIVE: The goal of this qualitative study was to identify facilitators and barriers to acceptability of a biopsy-first approach to rule out endometrial cancer among cisgender Black women. STUDY DESIGN: In this community-engaged qualitative study, 3 focus groups were conducted among cisgender Black women at risk for endometrial cancer. Convenience sampling was carried out using social media and newsletter networks. A focus group guide was developed based on the theory of planned behavior and contained questions about past experiences, initial impressions of a biopsy-first approach, an educational presentation, and final thoughts about a biopsy-first approach. Transcripts of focus group recordings were coded using a combined inductive and deductive approach and analyzed using directed and thematic content analysis. RESULTS: Twenty-five women participated in focus groups (Table 1), with 6 to 10 participants per group. Participants initially expressed understandable apprehension and rejection of a biopsy-first approach in the context of symptom presentation, informed by concerning past experiences and awareness of medical racism. Yet, by the end of the focus groups, there was overall acceptability of biopsy as a priority test to rule out endometrial cancer. Barriers of biopsy acceptability include negative past experiences, including mismatch of pain expectations with actual experiences, and known incidents of medical racism. Facilitators of biopsy acceptability included fostering patient-provider trust through explicit acknowledgment of medical racism, sharing information, personalized recommendations, and racial concordance in care; and health education about racial disparities in endometrial cancer, the biopsy procedure, physical risks of forgoing biopsy, emotional benefits of biopsy, and the range of possible pain experiences. CONCLUSION: This qualitative study describes Black cisgender women's perspectives on biopsy as a first-line approach in evaluating abnormal bleeding to rule out endometrial cancer in this population. We find that a patient-centered communication approach that incorporates trust-building, shared decision-making, and education may be most successful when recommending biopsy. These findings can inform culturally competent clinical guideline development and public health education to improve timely diagnosis-and ultimately survival-of endometrial cancer among Black women.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Alson JG, Orellana M, Robinson WR, et al. Facilitators and barriers to acceptability of a biopsy-first approach in the diagnostic evaluation for endometrial cancer among Black women. Am J Obstet Gynecol. 2025. PMID: 40086562. doi:10.1016/j.ajog.2025.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。